SCHEMBL30096979

SCHEMBL30096979

Cc1cc(Cl)ncc1C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 7/20 0.59
SIRT3 Q9NTG7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
GABRA4 P48169 1/20 0.46
GABRE P78334 1/20 0.46
GABRA6 Q16445 1/20 0.46
GABRG1 Q8N1C3 1/20 0.46
GABRG3 Q99928 1/20 0.46
GABRQ Q9UN88 1/20 0.46
SIRT6 Q8N6T7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22291660 1.00 NNMT (0.59) NNMTSIRT3TDP1GABRPGABRD
SCHEMBL15547132 0.84 GABRP (0.44) NNMTGABRPGABRDGABRA1GABRB1
SCHEMBL3752864 0.82 GABRP (0.61) NNMTGABRPGABRDGABRA1GABRB1
SCHEMBL15713423 0.82 KCNQ3 (0.43) NNMTTDP1GABRPGABRDGABRA1
SCHEMBL30414922 0.82 KCNQ3 (0.43) NNMTTDP1GABRPGABRDGABRA1
SCHEMBL30197143 0.80 NNMT (0.62) NNMTSIRT3TDP1GABRPGABRD
SCHEMBL29799541 0.80 NNMT (0.61) NNMTSIRT6SLC2A1MKNK1MKNK2
SCHEMBL384113 0.80 NNMT (0.61) NNMTSIRT6SLC2A1MKNK1MKNK2
SCHEMBL5009904 0.80 NNMT (0.62) NNMTSIRT3TDP1GABRPGABRD
SCHEMBL17362420 0.78 SIRT6 (0.47) NNMTTDP1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009719-A2 STABILITY-ENHANCING COMPOSITIONS AND METHODS OF PREPARING COMPOUNDS FOGHORN THERAPEUTICS INC. (US) 2023-02-02 WO disclosed
WO-2023009701-A2 THERAPEUTIC REGIMENS OF A DEGRADER OF BRD9 FOGHORN THERAPEUTICS INC. (US) 2023-02-02 WO disclosed
WO-2023283263-A1 CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME FOGHORN THERAPEUTICS INC. (US) 2023-01-12 WO disclosed
EP-4096651-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed